Ripple has raised $500 million in new funding round, at a $40 billion valuation. Strategic investment signals strong confidence in XRP and Ripple USD stablecoin. Momentum has seen Ripple close mega deals in 2025. Ripple, the enterprise blockchain leader in cross-border payments, has secured a landmark $500 million strategic investment, with its valuation at $40 […] The post Ripple announces $500M raise at $40 billion valuation appeared first on CoinJournal.Ripple has raised $500 million in new funding round, at a $40 billion valuation. Strategic investment signals strong confidence in XRP and Ripple USD stablecoin. Momentum has seen Ripple close mega deals in 2025. Ripple, the enterprise blockchain leader in cross-border payments, has secured a landmark $500 million strategic investment, with its valuation at $40 […] The post Ripple announces $500M raise at $40 billion valuation appeared first on CoinJournal.

Ripple announces $500M raise at $40 billion valuation

  • Ripple has raised $500 million in new funding round, at a $40 billion valuation.
  • Strategic investment signals strong confidence in XRP and Ripple USD stablecoin.
  • Momentum has seen Ripple close mega deals in 2025.

Ripple, the enterprise blockchain leader in cross-border payments, has secured a landmark $500 million strategic investment, with its valuation at $40 billion.

Led by global investment giants Fortress Investment Group and Citadel Securities, the raise signals investor confidence in Ripple and its expanding role in global finance.

Ripple raises $500 million funding round

On Wednesday, November 5, 2025, as the crypto market grappled with sell-off pressure, Ripple delivered one of the biggest news .

The company announced it had secured $500 million in fresh funding, with the financing round valuing it at $40 billion.

Apart from Fortress Investment Group and Citadel Securities, participation attracted Pantera Capital, Galaxy Digital, Brevan Howard, and Marshall Wace.

Overall, this is a funding move that marks one of the largest private financings in the blockchain sector this year.

The raise comes after Ripple’s recent $1 billion tender offer at the same valuation.

Meanwhile, it’s a move that caps what the firm and its leadership have described as the crypto industry giant’s strongest year on record.

Brad Garlinghouse, the chief executive officer of Ripple, described the funding as validation of Ripple’s long-term vision.

Ripple will tap into the new capital to support key platfom initiatives.

These will include product development, global regulatory engagement, and expansion of Ripple’s liquidity solutions.

Also on card are the company’s stablecoin initiative and custody services.

Ripple continues mega growth trajectory

The capital injection arrives amid a banner stretch for Ripple.

Payment volumes on the XRP Ledger have surged, as has adoption for the firm’s regulated stablecoin, Ripple USD (RLUSD).

Indeed, RLUSD recently surged past a $1 billion market cap.

Elsewhere, Ripple Prime, the institutional brokerage arm born from the acquisition of Hidden Road, is live.

These are only a few of the many milestones in Ripple’s transformation from a remittance-focused startup to a full-stack financial-technology provider.

In the past few months, the company has closed multiple deals, including those valued at $1 billion.

October’s purchase of GTreasury came after the earlier acquisition of Rail as Ripple looked to fortify its stablecoin footprint.

The company has also expanded its US presence with a New York trust charter earlier this year, enabling regulated custody and payment services.

The post Ripple announces $500M raise at $40 billion valuation appeared first on CoinJournal.

Market Opportunity
XRP Logo
XRP Price(XRP)
$2.0639
$2.0639$2.0639
-1.55%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23